Insider trades
Adam M. Veness, SVP of Dianthus Therapeutics DNTH, has filed 0 purchases and 2 sales on the open market. Over the past 12 months that comes to a net sale of $2.4M. The latest trade was on 06/17.
Adam M. Veness
SVP, General Counsel and Sec
- Company
- Dianthus Therapeutics DNTH
- First filing
- 23/02/07
- Trades
- 9 trades
- Buys / sales
- 0 / 2
- 12-month net buying
- −$2.4M
- Last trade
- 06/17